Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2016 1
2018 1
2019 2
2021 1
2022 1
2023 4
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

9 results

Results by year

Filters applied: . Clear all
Page 1
Cord blood transplantation for nonmalignant disorders: early functional immunity and high survival.
Martinez C, Aguayo-Hiraldo P, Chaimowitz N, Forbes L, Rider N, Nicholas S, Seeborg F, Chinen J, Chinn I, Davis C, Roseblatt H, Noroski L, Omer B, John T, Yassine K, Naik S, Craddock J, Bhar S, Allen C, Ahmed N, Sasa G, Steffin D, Doherty E, George A, Salem B, Friend B, Hegde M, Brenner MK, Heslop HE, Leen A, Peña A, Wu M, Hanson IC, Krance RA. Martinez C, et al. Among authors: salem b. Blood Adv. 2023 May 9;7(9):1823-1830. doi: 10.1182/bloodadvances.2022009038. Blood Adv. 2023. PMID: 36453638 Free PMC article. Clinical Trial.
Hematopoietic stem cell transplantation for B-thalassemia major with alemtuzumab.
Sánchez LM, George A, Friend BD, Bhar S, Sasa G, Doherty EE, Craddock J, Steffin D, Salem B, Yassine K, Omer B, Martinez C, Leung K, Krance RA, John TD. Sánchez LM, et al. Among authors: salem b. Pediatr Hematol Oncol. 2024 May;41(4):260-272. doi: 10.1080/08880018.2023.2296933. Epub 2023 Dec 22. Pediatr Hematol Oncol. 2024. PMID: 38131101
Blinatumomab Therapy Is Associated with Favorable Outcomes after Allogeneic Hematopoietic Cell Transplantation in Pediatric Patients with B Cell Acute Lymphoblastic Leukemia.
Llaurador G, Shaver K, Wu M, Wang T, Gillispie A, Doherty E, Craddock J, Read J, Yassine K, Morales E, George A, Steffin D, Krance R, Martinez C, Heslop H, Salem B. Llaurador G, et al. Among authors: salem b. Transplant Cell Ther. 2024 Feb;30(2):217-227. doi: 10.1016/j.jtct.2023.10.024. Epub 2023 Nov 4. Transplant Cell Ther. 2024. PMID: 37931800
Rituximab as adjunctive therapy to BEAM conditioning for autologous stem cell transplantation in Hodgkin lymphoma.
Friend BD, Muhsen IN, Patel S, Hill LC, Lulla P, Ramos CA, Pingali SR, Kamble RT, John TD, Salem B, Bhar S, Doherty EE, Craddock J, Sasa G, Wu M, Wang T, Martinez C, Krance RA, Heslop HE, Carrum G. Friend BD, et al. Among authors: salem b. Bone Marrow Transplant. 2022 Apr;57(4):579-585. doi: 10.1038/s41409-022-01599-5. Epub 2022 Feb 1. Bone Marrow Transplant. 2022. PMID: 35105965
Safety and feasibility of virus-specific T cells derived from umbilical cord blood in cord blood transplant recipients.
Abraham AA, John TD, Keller MD, Cruz CRN, Salem B, Roesch L, Liu H, Hoq F, Grilley BJ, Gee AP, Dave H, Jacobsohn DA, Krance RA, Shpall EJ, Martinez CA, Hanley PJ, Bollard CM. Abraham AA, et al. Among authors: salem b. Blood Adv. 2019 Jul 23;3(14):2057-2068. doi: 10.1182/bloodadvances.2019000201. Blood Adv. 2019. PMID: 31292125 Free PMC article.